KPV is a tripeptide fragment of alpha-MSH studied for anti-inflammatory and antimicrobial signaling, often discussed in gut-health research alongside BPC-157.
Benefits
KPV (Lysine-Proline-Valine) is a tripeptide — the C-terminal fragment of alpha-MSH. Evidence found is entirely from mouse colitis models; no human trial was found.
Anti-inflammatory mechanism: at nanomolar concentrations, KPV inhibits NF-κB and MAP kinase inflammatory signaling, reducing pro-inflammatory cytokine production. Uptake is via the PepT1 transporter in intestinal/immune cells — notably, this anti-inflammatory effect is reported as PepT1-mediated rather than melanocortin-receptor-mediated, despite KPV's origin as an alpha-MSH fragment. Dalmasso et al., Gastroenterology, 2008
Colitis models — animal studies: oral KPV reduced disease severity in both DSS-induced and TNBS-induced colitis. In a separate study using two colitis models plus mice with non-functional melanocortin-1 receptors, KPV produced earlier weight recovery and reduced inflammatory infiltrates — and in the receptor-deficient mice specifically, KPV treatment "rescued all animals in the treatment group from death during DSS colitis," reinforcing that its effect doesn't depend on standard melanocortin receptor signaling. Kannengiesser et al., Inflamm Bowel Dis, 2008
Dosage
No human trial has established a dose. The mouse colitis studies used 100μM KPV administered orally via drinking water (whole-animal dosing, not directly convertible to a human dose) and 10nM in cell culture experiments. Community-use conventions (200-500mcg subcutaneous daily; 1,000-1,500mcg oral daily) are widely discussed but don't trace back to a clinical trial.
Side Effects
No dedicated human safety study was found. Preclinical/mouse data doesn't show adverse findings at the doses tested, but this is a genuine evidence gap, not a documented clean human safety record — KPV's evidence base is thinner than most compounds on this site, and that's worth stating plainly rather than implying otherwise.
What is KPV researched for?+
Anti-inflammatory and antimicrobial research, particularly in gut-health contexts.
Is KPV FDA-approved?+
No, it is not an approved drug and is sold for research use only.
Is KPV related to Melanotan?+
It is derived from the same parent hormone (alpha-MSH) as Melanotan I/II, but KPV is studied for anti-inflammatory effects rather than pigmentation.
Will KPV fix my skin?+
It's researched for calming inflammatory skin conditions like eczema and rosacea by turning down inflammatory signaling — think 'calms the flare-up' rather than a cosmetic fix.
Results depend heavily on what's actually driving your specific skin issue.
Will KPV make my stomach pain or gut inflammation go away?+
That's actually its best-known research use — KPV is studied specifically for gut inflammation and IBD-type conditions.
Most people researching it for gut issues use it orally rather than by injection, and it typically takes a consistent 4-6 weeks before you'd expect to notice a real difference.
Why do people stack it with BPC-157?+
Because the two attack the same problem from different angles — BPC-157 helps repair the gut lining itself, while KPV calms the inflammation that's damaging it in the first place. Repair plus calm.
Oral vs. injectable for gut use — which is better?+
For gut health specifically, oral is usually the better route. There's a transporter system in inflamed intestinal tissue (PepT1) that actively pulls KPV into the cells that need it, and injecting it under the skin bypasses that mechanism entirely.
Injection makes more sense for inflammation that isn't gut-specific. It's one of the rare cases where oral delivery beats injection for the target use.
Who is KPV for?+
People dealing with chronic gut inflammation or IBD-related conditions, people who want anti-inflammatory support without broader immune suppression, people running GLP-1s who get GI side effects, people with inflammatory skin conditions looking for a targeted approach, and people who'd rather take something orally than inject it.
Who is KPV not for?+
People looking for a general recovery or muscle-repair peptide — BPC-157 and TB-500 are better fits for that.
Also not a great match if you're expecting overnight results on a chronic inflammatory condition, or if you're not willing to stay consistent with daily dosing for at least 4-6 weeks.
Looking for something specific, or placing a wholesale order? Send us a DM or email.